Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.

Weiwei GongYueyang LiuChristof SeidlEleftherios P DiamandisMarion KiechleEnken DrecollMatthias KotzschViktor MagdolenJulia Dorn

Published in: BMC cancer (2019)

These results obtained with a homogenous patient group with all patients suffering from advanced high-grade serous ovarian cancer support previous results suggesting elevated KLK5 mRNA levels as an unfavorable marker in ovarian cancer.

Keyphrases

high grade
low grade
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
case report
high resolution
mass spectrometry
drug induced